Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 725 of 1958 entries
View as:

A Study of Nasal Glucagon in Participants With a Common Cold

Phase: N/A Priority: Normal
NCT ID: NCT02778100 Org: User:
Start: 03/31/13 End: 04/30/13 Due: 04/30/14

A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation

Phase: N/A Priority: Normal
NCT ID: NCT04280081 Org: User:
Start: 03/16/20 End: 11/30/27 Due: 11/30/28

A Study in Depression and Associated Painful Physical Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT01070329 Org: User:
Start: 03/31/10 End: 03/31/11 Due: 03/31/12

A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread

Phase: N/A Priority: Normal
NCT ID: NCT02057133 Org: User:
Start: 03/10/14 End: 12/31/25 Due: 12/31/26

A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations

Phase: N/A Priority: Normal
NCT ID: NCT01897480 Org: User:
Start: 08/28/13 End: 12/31/25 Due: 12/31/26

A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease

Phase: N/A Priority: Normal
NCT ID: NCT00191373 Org: User:
Start: 03/31/02 End: 07/31/07 Due: 07/31/08

Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia

Phase: N/A Priority: Normal
NCT ID: NCT00607919 Org: User:
Start: 03/31/08 End: 02/28/11 Due: 02/28/12

A Study of LY2624803 in Japanese Participants With Transient Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT01784614 Org: User:
Start: 09/30/09 End: 03/31/10 Due: 03/31/11

A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury

Phase: N/A Priority: Normal
NCT ID: NCT00036062 Org: User:
Start: 08/31/01 End: 12/31/02 Due: 12/31/03

Effect of LY2062430 on the Progression of Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00905372 Org: User:
Start: 05/31/09 End: 04/30/12 Due: 04/30/13

A Study of Baricitinib (LY3009104) in Healthy Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT02758613 Org: User:
Start: 05/31/16 End: 07/31/16 Due: 07/31/17

A Study of LY2784544 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01577355 Org: User:
Start: 04/30/12 End: 06/30/12 Due: 06/30/13

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT05556512 Org: User:
Start: 10/11/22 End: 10/31/27 Due: 10/31/28

A First-In-Human Study of LY3839840 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06153355 Org: User:
Start: 12/04/23 End: 05/22/25 Due: 05/22/26

A Study of Dulaglutide in Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT01667900 Org: User:
Start: 08/31/12 End: 06/30/14 Due: 06/30/15

Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT00617734 Org: User:
Start: 03/31/08 End: 07/31/12 Due: 07/31/13

A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00122850 Org: User:
Start: 10/31/04 End: 11/30/05 Due: 11/30/06

A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01029795 Org: User:
Start: 02/28/10 End: 06/30/10 Due: 06/30/11

Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00036309 Org: User:
Start: 05/31/02 End: 07/31/03 Due: 07/31/04

Evaluation of Continuous Symptom Treatment of ADHD

Phase: N/A Priority: Normal
NCT ID: NCT00486122 Org: User:
Start: 09/30/03 End: 06/30/04 Due: 06/30/05

A Study for Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00548808 Org: User:
Start: 11/30/07 End: 08/31/09 Due: 08/31/10

Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00782002 Org: User:
Start: 07/31/06 End: 11/30/09 Due: 11/30/10

Bone Effects of Teriparatide Following Alendronate

Phase: N/A Priority: Normal
NCT ID: NCT00191893 Org: User:
Start: 09/30/03 End: 11/30/06 Due: 11/30/07

A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06859268 Org: User:
Start: 03/05/25 End: 04/30/28 Due: 04/30/29

A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)

Phase: N/A Priority: Normal
NCT ID: NCT03305809 Org: User:
Start: 11/09/17 End: 07/10/20 Due: 07/10/21